| Literature DB >> 30117059 |
Lara Kohler1, Rosa Puertollano2, Nina Raben3.
Abstract
Pompe disease is a rare and deadly muscle disorder. As a clinical entity, the disease has been known for over 75 years. While an optimist might be excited about the advances made during this time, a pessimist would note that we have yet to find a cure. However, both sides would agree that many findings in basic science-such as the Nobel prize-winning discoveries of glycogen metabolism, the lysosome, and autophagy-have become the foundation of our understanding of Pompe disease. The disease is a glycogen storage disorder, a lysosomal disorder, and an autophagic myopathy. In this review, we will discuss how these past discoveries have guided Pompe research and impacted recent therapeutic developments.Entities:
Keywords: Glycogen storage; autophagy; enzyme replacement therapy; lysosome; myopathy; newborn screening
Mesh:
Year: 2018 PMID: 30117059 PMCID: PMC6277280 DOI: 10.1007/s13311-018-0655-y
Source DB: PubMed Journal: Neurotherapeutics ISSN: 1878-7479 Impact factor: 7.620